TY - JOUR T1 - Genomics of Indian SARS-CoV-2: Implications in genetic diversity, possible origin and spread of virus JF - medRxiv DO - 10.1101/2020.04.25.20079475 SP - 2020.04.25.20079475 AU - Mainak Mondal AU - Ankita Lawarde AU - Kumaravel Somasundaram Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/29/2020.04.25.20079475.abstract N2 - World Health Organization (WHO) declared COVID-19 as a pandemic disease on March 11, 2020. Comparison of genome sequences from diverse locations allows us to identify the genetic diversity among viruses which would help in ascertaining viral virulence, disease pathogenicity, origin and spread of the SARS-CoV-2 between countries. The aim of this study is to ascertain the genetic diversity among Indian SARS-CoV-2 isolates. Initial examination of the phylogenetic data of SARS-CoV-2 genomes (n=3123) from different continents deposited at GISAID (Global Initiative on Sharing All Influenza Data) revealed multiple origin for Indian isolates. An in-depth analysis of 449 viral genomes derived from samples representing countries from USA, Europe, China, East Asia, South Asia, Oceania, Middle East regions and India revealed that most Indian samples are divided into two clusters (A and B) with cluster A showing more similarity to samples from Oceania and Kuwait and the cluster B grouping with countries from Europe, Middle East and South Asia. Diversity analysis of viral clades, which are characterized by specific non-synonymous mutations in viral proteins, discovered that the cluster A Indian samples belong to I clade (V378I in ORF1ab), which is an Oceania clade with samples having Iran connections and the cluster B Indian samples belong to G clade (D614G in Spike protein), which is an European clade. Thus our study identifies that the Indian SARS-CoV-2 viruses belong to I and G clades with potential origin to be countries mainly from Oceania, Europe, Middle East and South Asia regions, which strongly implying the spread of virus through most travelled countries. The study also emphasizes the importance of pathogen genomics through phylogenetic analysis to discover viral genetic diversity and understand the viral transmission dynamics with eventual grasp on viral virulence and disease pathogenesis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKS acknowledges DBT, DST-SERB and ICMR, Government of India for Research grant. Infrastructure support by funding from DST-FIST, IISc-DBT partnership and UGC (Centre for Advanced Studies in Molecular Microbiology) to MCB is acknowledged. KS is a J. C. Bose Fellow of the Department of Science and Technology.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is taken from www.gisaid.orgSARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus 2COVID-19Coronavirus disease 19WHOWorld Health OrganizationGISRSGlobal Influenza Surveillance and Response SystemGISAIDGlobal Initiative on Sharing All Influenza Data ER -